
Martin Zapata Laguado/LinkedIn
Jun 2, 2025, 06:41
Martin Zapata Laguado: New players in the management of mRCC patients
Martin Zapata Laguado, Clinical Oncologist at the National Cancer Institute E.S.E., shared on X:
“ASCO 2025 new players in the management of mRCC patients with casdatifan plus a great TKI, shows similar data on toxicity compared to others antihif therapies.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 19, 2025, 15:16
Aug 19, 2025, 15:10
Aug 19, 2025, 14:30
Aug 19, 2025, 14:30
Aug 19, 2025, 14:14
Aug 19, 2025, 13:17
Aug 19, 2025, 13:14